Emcure Pharmaceuticals Q1 FY26 performance was bolstered by healthy momentum across both domestic and international markets.
Read MoreSatish Mehta
Emcure Secures Exclusive Distribution Rights for Sanofi India’s Oral Anti-diabetic Drugs
Emcure will exclusively promote and distribute Sanofi’s oral anti-diabetic drugs brands, including the widely prescribed Amaryl and Cetapin, throughout India.
Read More
Emcure Pharmaceuticals Posts 63 Per Cent PAT Growth in Q4FY25
Emcure Pharmaceuticals continues to expand its presence in 70+ countries, including major global markets like Europe and Canada.
Read More